Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 36 of 47
  1. Sulfasalazine

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial
  2. Sumatriptan succinate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials
  3. TAK-004

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. TAK-020

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  5. TAK-020 Captisol Oral Solution

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  6. TAK-041

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  7. TAK-058

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  8. TAK-063

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  9. TAK-105-a

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  10. TAK-123

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  11. TAK-137 5 mg tablet, TAK-137 placebo tablet

    Takeda

    Healthy Japanese Adult Male

    phase 1 small molecule terminated

    1 trial
  12. TAK-227

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. TAK-272

    Takeda

    Japanese Healthy Adult Males

    phase 1 small molecule completed

    1 trial
  14. TAK-279

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials
  15. TAK-385 40 mg

    Takeda

    Japanese Premenopausal Healthy Adult Women

    phase 1 small molecule completed

    1 trial
  16. TAK-385 T2 Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. TAK-418

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  18. TAK-418

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    2 trials
  19. TAK-438

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. TAK-438

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  21. TAK-438 OD

    Takeda

    Japanese Healthy Adult Male

    phase 1 small molecule completed

    1 trial
  22. TAK-438ASA

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  23. TAK-491

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial
  24. TAK-510

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.